lobbying_activities: 2825859

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2825859	3ff639a5-50b7-48a6-899b-634896701271	Q2	340B HEALTH	316434	340B HEALTH	2022	second_quarter	PHA	The 340B Drug Pricing Program; H.R.4390 - PROTECT 340B Act of 2021; Labor HHS Appropriations FY 2023; HR853 Closing Loopholes for Orphan Drugs Act; S. 2837, the 340B Accountability Act of 2021	Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE		298834	0	0	2022-07-18T17:07:22-04:00